ESR1 and neoplasm: Histologic review of each PDX was performed, primarily to determine how closely each tumor matched the original patient tumor in terms of morphology and immunohistochemical staining patterns for estrogen receptor, progesterone receptor, HER2, and Ki67 [10, 11].